IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Davern Capital Partners, LP

Portfolio Profile

CIK: 0002003147 | NY, NY

Investment Profile

Style

Value

Turnover

High

Orientation

Concentrated trader
$586.5M
AUM
15
Positions
86.76%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Biontech SE(BNTX)754,550$70.2M11.97%
2Roivant Sciences LTD(ROIV)1,932,904$68.4M11.66%
3Royalty Pharma PLC(RPRX)1,155,809$64.8M11.05%
4Ionis Pharmaceuticals Inc(IONS)798,709$63.3M10.80%
5Insmed Inc(INSM)559,824$59.7M10.18%
6

Sector Allocation

Latest filing, equity positions only

Healthcare74.92% · $439.4M
Unclassified25.08% · $147.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare84.49%74.92%-9.57%
Unclassified15.51%25.08%+9.57%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$309.3M | 14 pos.
$364.5M | 17 pos.
$586.5M | 15 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

3
New
5
Regeneron Pharmaceuticals(REGN)
92,640
$57.8M
9.85%
7Legend Biotech Corp(LEGN)1,191,522$34.4M5.87%
8Alnylam Pharmaceuticals Inc(ALNY)113,085$34.0M5.80%
9Natera Inc(NTRA)118,975$32.3M5.51%
10Structure Therapeutics Inc(GPCR)446,059$23.9M4.08%
Cap SizePrev %Curr %Change
Large Cap60.29%54.1%-6.19%
Unclassified15.51%25.08%+9.57%
Mid Cap12.21%13.6%+1.39%
Small Cap5.11%5.74%+0.63%
Micro Cap0%1.48%+1.48%
Mega Cap6.88%0%-6.88%
Closed
10
Increased
2
Decreased
0
Unchanged